Skip to content

Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)

Sensor-based Congestion Alert for Events in Peritoneal Dialysis (SCALE-PD)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07059962
Acronym
SCALE-PD
Enrollment
125
Registered
2025-07-11
Start date
2025-09-09
Completion date
2026-06-01
Last updated
2026-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Kidney Disease (ESRD), Kidney Disease, Peritoneal Dialysis (PD)

Keywords

kidney disease, peritoneal dialysis, fluid overload, heart failure

Brief summary

To explore the use of the Bodyport Cardiac Scale in predicting worsening of events due to fluid overload in patients with kidney disease on peritoneal dialysis.

Detailed description

The objective of this study is to explore the utility of hemodynamic biomarkers measured by the Bodyport Cardiac Scale in predicting worsening events attributable to fluid overload among those with kidney disease on peritoneal dialysis. The study will explore individual biomarkers, as well as composite biomarker indices, such as the Congestion Index and a novel PD Index.

Interventions

The Bodyport Cardiac Scale captures several physiological signals, which are used to derive multiple biomarkers that reflect a user's hemodynamic and fluid status.

Sponsors

Bodyport Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age 21 years or older 2. Able to speak and read English, or able to speak and read Spanish and has a caregiver or family member who speaks English and can provide assistance 3. Able to stand on two bare feet unassisted 4. Receiving automated peritoneal dialysis for the treatment of ESKD 5. Followed on the Vantive Sharesource Remote Patient Management Platform

Exclusion criteria

1. Undergoing or plan to undergo hemodialysis in the next 12 months 2. Have a life expectancy of less than 12 months 3. Are pregnant or plan to become pregnant during the next 12 months 4. Weigh greater than 375 lbs 5. Planned kidney transplant within the next 12 months 6. Have an implanted neurostimulator system

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity Analysis1 yearSensitivity for predicting usable PDE \> 0.40 and an alert rate of \< 4.3 alerts per patient-year.

Secondary

MeasureTime frameDescription
Peritoneal Dialysis (PD) Events1 yearCollection of approximately 40 usable PD Events for model development and validation. These events are defined as urgent, unscheduled clinic visits or emergency department visits or hospital admissions for worsening fluid overload and initiation or intensification of treatment for fluid overload or termination of treatment due to fluid related cause.

Countries

Canada, United States

Contacts

CONTACTCorey Centen
corey@bodyport.com415-990-5415
CONTACTDorothy Kwok
dorothy@bodyport.com669-240-3077

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026